Cargando…

Artesunate suppresses Th17 response via inhibiting IRF4-mediated glycolysis and ameliorates Sjog̈ren’s syndrome

Detalles Bibliográficos
Autores principales: Xiao, Fan, Rui, Ke, Han, Man, Zou, Liyun, Huang, Enyu, Tian, Jie, Zhang, Lijun, Jiang, Quan, Wu, Yuzhang, Lu, Liwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420730/
https://www.ncbi.nlm.nih.gov/pubmed/36031634
http://dx.doi.org/10.1038/s41392-022-01103-x
_version_ 1784777453801046016
author Xiao, Fan
Rui, Ke
Han, Man
Zou, Liyun
Huang, Enyu
Tian, Jie
Zhang, Lijun
Jiang, Quan
Wu, Yuzhang
Lu, Liwei
author_facet Xiao, Fan
Rui, Ke
Han, Man
Zou, Liyun
Huang, Enyu
Tian, Jie
Zhang, Lijun
Jiang, Quan
Wu, Yuzhang
Lu, Liwei
author_sort Xiao, Fan
collection PubMed
description
format Online
Article
Text
id pubmed-9420730
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-94207302022-08-30 Artesunate suppresses Th17 response via inhibiting IRF4-mediated glycolysis and ameliorates Sjog̈ren’s syndrome Xiao, Fan Rui, Ke Han, Man Zou, Liyun Huang, Enyu Tian, Jie Zhang, Lijun Jiang, Quan Wu, Yuzhang Lu, Liwei Signal Transduct Target Ther Letter Nature Publishing Group UK 2022-08-29 /pmc/articles/PMC9420730/ /pubmed/36031634 http://dx.doi.org/10.1038/s41392-022-01103-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Xiao, Fan
Rui, Ke
Han, Man
Zou, Liyun
Huang, Enyu
Tian, Jie
Zhang, Lijun
Jiang, Quan
Wu, Yuzhang
Lu, Liwei
Artesunate suppresses Th17 response via inhibiting IRF4-mediated glycolysis and ameliorates Sjog̈ren’s syndrome
title Artesunate suppresses Th17 response via inhibiting IRF4-mediated glycolysis and ameliorates Sjog̈ren’s syndrome
title_full Artesunate suppresses Th17 response via inhibiting IRF4-mediated glycolysis and ameliorates Sjog̈ren’s syndrome
title_fullStr Artesunate suppresses Th17 response via inhibiting IRF4-mediated glycolysis and ameliorates Sjog̈ren’s syndrome
title_full_unstemmed Artesunate suppresses Th17 response via inhibiting IRF4-mediated glycolysis and ameliorates Sjog̈ren’s syndrome
title_short Artesunate suppresses Th17 response via inhibiting IRF4-mediated glycolysis and ameliorates Sjog̈ren’s syndrome
title_sort artesunate suppresses th17 response via inhibiting irf4-mediated glycolysis and ameliorates sjog̈ren’s syndrome
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420730/
https://www.ncbi.nlm.nih.gov/pubmed/36031634
http://dx.doi.org/10.1038/s41392-022-01103-x
work_keys_str_mv AT xiaofan artesunatesuppressesth17responseviainhibitingirf4mediatedglycolysisandamelioratessjogrenssyndrome
AT ruike artesunatesuppressesth17responseviainhibitingirf4mediatedglycolysisandamelioratessjogrenssyndrome
AT hanman artesunatesuppressesth17responseviainhibitingirf4mediatedglycolysisandamelioratessjogrenssyndrome
AT zouliyun artesunatesuppressesth17responseviainhibitingirf4mediatedglycolysisandamelioratessjogrenssyndrome
AT huangenyu artesunatesuppressesth17responseviainhibitingirf4mediatedglycolysisandamelioratessjogrenssyndrome
AT tianjie artesunatesuppressesth17responseviainhibitingirf4mediatedglycolysisandamelioratessjogrenssyndrome
AT zhanglijun artesunatesuppressesth17responseviainhibitingirf4mediatedglycolysisandamelioratessjogrenssyndrome
AT jiangquan artesunatesuppressesth17responseviainhibitingirf4mediatedglycolysisandamelioratessjogrenssyndrome
AT wuyuzhang artesunatesuppressesth17responseviainhibitingirf4mediatedglycolysisandamelioratessjogrenssyndrome
AT luliwei artesunatesuppressesth17responseviainhibitingirf4mediatedglycolysisandamelioratessjogrenssyndrome